The direction of the growth hormone axis is the opposite of weight gain. In a 6-month GHRH-analog trial, visceral fat and overall adiposity went down while lean mass went up. If the scale rises on sermorelin, the cause is water or muscle, not fat.
Sermorelin does not cause fat gain. The growth hormone axis it stimulates pushes body composition in the opposite direction: toward less fat and more lean mass. The only ways the number on the scale can rise are transient water retention or added lean tissue, and neither of those is fat. Understanding which is which is the whole answer to this question.
- Sermorelin does not cause fat gain. The GH axis favors fat loss and lean mass [1][4]
- In a 6-month GHRH-analog trial, visceral fat and overall adiposity decreased while lean mass increased [1]
- A short-term rise on the scale is usually water retention or added lean tissue, not fat
- Growth hormone antagonizes insulin and increases fat mobilization for fuel [2]
- Track waist circumference and IGF-1, not scale weight alone, to see what is actually changing
What the GH Axis Does to Body Composition
Sermorelin raises growth hormone, which the liver converts to IGF-1. The downstream effect on body composition is well characterized in GHRH-analog trials. Tesamorelin, a GHRH analog, decreased visceral fat and overall adiposity and increased lean mass over 6 months [1]. That is the direction of travel the axis produces: fat down, lean tissue up.
The mechanism supports it. Growth hormone antagonizes insulin action and increases the flux of free fatty acids [2], which is the biochemistry of mobilizing fat for fuel rather than storing it. In the long-term GHRH-analog trial, insulin sensitivity improved in men [3]. None of that is a profile that adds fat.
Why the Scale Might Go Up Anyway
Patients sometimes see the scale tick up in the first weeks and reasonably worry about weight gain. There are two explanations, and neither is fat.
- Lean mass. Muscle is denser than fat, so building lean tissue can hold scale weight steady or nudge it up even as body fat falls and the waist shrinks
- Water. Growth hormone therapies can shift fluid balance, producing a temporary increase that reflects water, not tissue
The scale cannot distinguish fat from muscle from water. On a therapy that reduces fat and adds lean mass, a flat or slightly higher scale number is compatible with a leaner body. Waist circumference and how clothes fit are more honest than the morning weigh-in.
Water Retention, Specifically
Fluid retention is a recognized effect of the growth hormone class, most clearly documented with exogenous synthetic HGH (somatropin), where higher tissue exposure drives edema. With sermorelin the concern is smaller, because the somatostatin feedback loop stays intact and self-limits GH output, so oversaturation is unlikely at standard doses [4]. When mild fluid shifts do occur, they tend to appear early and settle rather than accumulate.
The practical point is that water weight is transient and is not fat. It does not represent the therapy failing or backfiring. If puffiness or joint stiffness is noticeable and persistent, that is a signal to review the dose with the prescriber, not evidence of fat gain.
When Weight Actually Increases on Sermorelin
Sermorelin is not a weight-loss drug, and it does not override diet. If total calories exceed what the body uses, weight can rise on sermorelin the same way it would without it. That is a nutrition outcome, not a drug effect. Unlike a GLP-1 medication, sermorelin does not suppress appetite, so it will not do the eating-behavior work for you.
This is why the honest framing is that sermorelin supports a body-composition shift rather than driving weight loss on its own. Paired with adequate protein and resistance training, the GH axis favors a leaner outcome. Paired with a calorie surplus, the surplus wins.
How to Tell Fat From Water From Muscle
- Waist circumference: the most accessible marker of visceral and overall fat change
- How clothing fits: a leaner composition shows here before the scale reflects it
- IGF-1 at baseline and 90 days: confirms the axis is responding as intended
- Body composition scan if available: separates lean mass from fat directly
- Timeline: early scale changes are usually water; fat change is a 6-month process [1]
A rising scale is hard to interpret without data. SystemLabs includes baseline IGF-1 testing and structured retesting, so you can confirm the axis is responding and read body composition change against a real starting point rather than the morning weigh-in.
Bottom Line
Sermorelin does not cause weight gain in the sense that worries people, which is fat gain. The GH axis it stimulates reduces fat and supports lean mass over a 6-month protocol. A short-term rise on the scale reflects water or added muscle, both of which are compatible with getting leaner. Judge the therapy by your waist and your labs, not the scale alone.
Frequently Asked Questions
Does sermorelin cause weight gain?
No, sermorelin does not cause fat gain. The growth hormone axis it stimulates reduces visceral fat and overall adiposity while increasing lean mass, as shown in a 6-month GHRH-analog trial. If the scale rises, the cause is transient water retention or added lean tissue, neither of which is fat.
Why did I gain weight on sermorelin?
Two explanations cover most cases, and neither is fat. Lean mass is denser than fat, so building muscle can hold or raise scale weight even as your waist shrinks. Growth hormone therapies can also shift fluid balance, producing a temporary water increase. If your total calories exceed what you burn, ordinary weight gain can also occur, since sermorelin does not suppress appetite.
Does sermorelin cause water retention?
Mild, transient fluid retention is possible, and it is far more pronounced with synthetic HGH than with sermorelin. Because sermorelin preserves the somatostatin feedback loop, GH output is self-limited and oversaturation is unlikely at standard doses. When fluid shifts occur they tend to be early and to settle. Persistent puffiness or joint stiffness is a reason to review the dose with your prescriber.
Does sermorelin make you lose or gain fat?
Lose. In GHRH-analog trials the axis decreased visceral fat and overall adiposity over 6 months, and growth hormone increases the mobilization of free fatty acids for fuel. Sermorelin is not a dedicated weight-loss drug, so results depend on diet and training, but the direction of the axis is fat reduction, not fat gain.
How do I know if it is fat, water, or muscle?
Do not rely on the scale, which cannot tell them apart. Track waist circumference and how your clothes fit for fat change, use a baseline and 90-day IGF-1 to confirm the axis is responding, and use a body composition scan if you have access to one. Early scale changes are usually water; genuine fat change is a process that takes about 6 months.
References
- Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies Growth Hormone & IGF Research, 2015. PMC4324360. https://pmc.ncbi.nlm.nih.gov/articles/PMC4324360/
- Biological effects of growth hormone on carbohydrate and lipid metabolism (growth hormone and insulin signaling) Molecular and Cellular Endocrinology, 2020. PMC7606590. https://pmc.ncbi.nlm.nih.gov/articles/PMC7606590/
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology & Metabolism, 1997. PMID: 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006. PMID: 18046908. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
